Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

Pediatric Pulmonology

Volumn 26, Issue 2, 1998, Pages 81-88

  Kosorok, Michael R ^a   Jalaluddin, Muhammad ^a   Farrell, Philip M ^a   Shen, Guanghong ^a   Colby, Christopher E ^a   Laxova, Anita ^a   Rock, Michael J ^a   Splaingard, Mark ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cystic fibrosis; Epidemiology; Infection; Pneumonia; Pseudomonas

Indexed keywords

ARTICLE; CHILD; CYSTIC FIBROSIS; EDUCATION; EXPOSURE; HUMAN; INFANT; MATERNAL BEHAVIOR; PHYSICIAN; POPULATION DENSITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STATISTICAL ANALYSIS; URBAN AREA;

AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MEDICAL HISTORY TAKING; ODDS RATIO; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; WISCONSIN;

EID: 0031873820     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K     Document Type: Article

References (28)

1. Wilmott RW, Tyson SL, Matthew DJ. Cystic fibrosis survival rates: The influence of allergy and Pseudomonas aeruginosa. Am J Dis Child. 1985; 139:669-671.
2. Wood RE. Prognosis. In Verlag GT, ed. Cystic Fibrosis. New York: Thieme-Stratton 1984:434-460.
3. diSant' Agnese PA, Anderson DH. Celiac syndrome IV. Chemotherapy in infection of the respiratory tract associated with cystic fibrosis of the pancreas. Am J Dis Child. 1946; 72,17-61.
4. Pier GB. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: Current status of the host bacterium interaction. J Infect Dis. 1985; 151:575-580.
5. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
6. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996; 335:179-188.
7. Zimakoff J, Hoiby N, Rosendal K, Guilbert JP. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J Hosp Infect. 1983; 4:31-10.
8. Pederson SS, Jensen T, Pressler T, Hoiby N, Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr Scand. 1986; 75: 840-845.
9. Pederson SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. J Antimicrob Chemother. 1986; 17:505-516.
10. Pederson SS, Jensen T, Hoiby N, Koch C, Flensborg EW. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1987; 76:955-961.
11. Hoiby N, Pedersen SS. Estimated risk of cross infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand. 1989; 78:395-404.
12. Fost N, Farrell PM. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: A unique ethical dilemma. Clin Res. 1989; 37:495-500.
13. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics. 1997; 100(s). URL: http://www.pediatrics.org/cgi/content/full/100/5/e2
14. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J Roy Stat Soc, Series B. 1976; 38:290-295.
15. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns T, Splaingard M, Mischler EH, and the Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Nutritional benefits of newborn screening for cystic fibrosis. N Engl J Med. 1997; 337:963-969.
16. van Egmond AWA, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr. 1996; 63:764-752.
17. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980:73-78.
18. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer, 1997.
19. Kosorok MR, Chao W-H. The analysis of longitudinal ordinal response data in continuous time. J Am Stat Assoc. 1996; 91:807-817.
20. Huber P. The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the 5th Berkeley Symposium. 1967; 1:221-234.
21. Zeger SL, Liang K-Y, Self SG. The analysis of binary longitudinal data with time-dependent covariates. Biometrika. 1985; 72:31-38.
22. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989:2649-2680.
23. di Sant' Agnese PA, Davis PB. Research in cystic fibrosis. N Engl J Med. 1976; 295:481-485.
24. Pierce AK, Sanford JP, Thomas GD. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. N Engl J Med. 1970; 282:528-531.
25. Reinarz JA, Pierce AK, Mays BB, Sanford JP. The potential role of inhalation therapy equipment in nosocomial pulmonary infection. J Clin Invest. 1965; 44:831-839.
26. Burdge DR, Nakielna EM, Noble MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. 1993; 14:127-130.
27. Hubbard RC, McElvancy NG, Birrer P, Shak S, Robinson WW, Jolle C, Wu M, Chernick MS, Crystal RG. A preliminary study of aerosolized recombinant human deoxyribonuclease in the treatment of cystic fibrosis. N Engl J Med 1992; 326:812-815.
28. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348:639-642.